Global Genome Editing Market Study Analysis: Pharmaceutical use of Genome Editing segment will boost the growth of the market in the forecast period

The global Genome Editing market size was valued at $5.5 Billion in 2020 and is expected to reach $11.4 Billion by 2028 growing at the CAGR of 17.3% from 2021 to 2028. Gene editing has emerged as a revolutionary tool for medical treatment. It is a method of adding, removing, or altering the DNA of an organism to cure particular diseases. If you are unaware, gene editing is a type of genetic engineering used to manipulate the genes of living organisms to treat certain diseases. By using a nuclease -a molecular scissor- certain parts of DNA can be removed, added, or altered creating site-specific double-stranded breaks at desirable locations in the genome that promote gene editing.

To request a free sample, Go To: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007061

Global Genome Editing Market Drivers And Restrain:
The main contributors to the growth of the Genome Editing market are technological advancements in gene-editing tools and the availability of government funding,

Availability of government funding:
Governments will provide increased funding for research into the development of genome editing tools. By investing in the development of cheaper and more effective gene-editing tools, governments will increase the size of the global genome editing market. In this way, this factor will increase the growth of these markets.
The market is hampered by the high cost of genomic equipment and rising concerns about the risks and ethical issues linked with genome editing

Impact Of COVID-19 on the Genome Editing Market:
• Impact on Market Size
• End-User Trend, Preferences, and Budget Impact
• Regulatory Framework/Government Policies
• Key Players Strategy to Tackle Negative Impact
• Opportunity Window

Global Genome Editing Market Segments:
The global Genome Editing market is further segmented into technology, product & service, application, end-user, and geography.
By Technology: CRISPR, TALEN, ZFN, Antisense
By Product & Service: Reagents & Consumables, Software & Systems, Services
By Application: Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development
By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic & Government Research Institutes

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa and South America)
North America will hold the largest market share owing to the availability of research grants and funding.

Key Players of Global Genome Editing Market:
• Thermo Fisher Scientific (US)
• Merck (Germany)
• Horizon Discovery Limited (UK)
• Lonza (Switzerland)
• GenScript (US)
• Eurofins Scientific (Luxembourg)
• Sangamo Therapeutics (US)
• Editas Medicine (US)
• CRISPR Therapeutics (Switzerland)
• Precision Biosciences (US)

For Any Query or Customization, Ask Our Industry Experts@https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=007061

Key Questioned Answered Through The Report:
• The Impact of COVID-19 on the global market
• What are the potential opportunities for new entrants in the global market
• What is the market Size and Forecast from 2020 to 2028?
• Key Players associated with the global Genome Editing Market
• Value Chain Analysis of Global Genome Editing Market
• What is the CAGR of the global Genome Editing Market from 2021 to 2028
• Major Growth Factor, Challenges, Trends, and Opportunities in the global market
• Key outcomes of SWOT Analysis

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advising service that offers creative solutions to a company's problems. Data beneficial to micro, small, medium, and large-scale businesses can be found in our market research studies. We offer a wide range of services, from data collection to business consulting.
Evolve Business Intelligence is built on account of technology advancement and our in-house AI-modelled data analysis and forecast tool - EvolveBI - provides extremely accurate data. This application tracks real-time statistics from Fortune's Global 2000 firms, including quarterly performance, annual performance, and recent changes.

This release was published on openPR.